Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia

American Journal of Hematology

Volumn 61, Issue 1, 1999, Pages 5-9

  Boultwood, Jackie ^a   Fidler, Carrie ^a   Shepherd, Patricia ^b   Watkins, Fiona ^a   Snowball, Joanna ^a   Haynes, Sara ^a   Kusec, Rajko ^c   Gaiger, Alex ^c   Littlewood, Timothy J ^a   Peniket, Andrew J ^a   Wainscoat, James S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Accelerated phase; Blast crisis; Chronic myelogenous leukemia; Leukemic transformation; Telomere

Indexed keywords

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; BLOOD SAMPLING; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; EVOLUTION; FEMALE; GENE REARRANGEMENT; HUMAN; LEUKEMIA CELL; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SARCOMERE LENGTH; TANDEM REPEAT; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; BLAST CRISIS; BLOTTING, SOUTHERN; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES; MIDDLE AGED; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERE;

EID: 0032891408     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199905)61:1<5::AID-AJH2>3.0.CO;2-4     Document Type: Article

References (17)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350: 569-572.
2. Blackburn EH. Telomeres: no end in sight. Cell 1994:77:621-623.
3. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-413.
4. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 1995;269:1236-1241.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
6. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;46:866-868.
7. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW. Telomerase activity in human breast tumors. J Nat Cancer Inst 1996;88:116-122.
8. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood 1993;82: 691-703.
9. Hughes TP, Goldman JM. Chronic myeloid leukemia. Huffman R, editor. Hematology, basic principles and practice. 2nd ed. New York: Churchill Livingstone; 1995. p 854-869.
10. Sokal JE, Cox EB, Baccarani M, Tura SS, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F, Rozman C, the Italian Cooperative CML Study Group. Prognostic discrimination in "good-risk" chronic granulocytic leukaemia. Blood 1984;63:789-799.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
12. Yamada O, Oshimi K, Motoji T, Miozoguchi H. Telomeric DNA in normal and leukemic blood cells. J Clin Invest 1995;95:1117-1123.
13. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54:3557-3560.
14. Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJW, Atoyebi O, Chapman R, Oscier DG, Wainscoat JS. Telomere length in the myelodysplastic syndromes. Am J Hematol 1997;56:266-271.
15. Fisher RA, Yates F. Statistical tables for biological, agricultural and medical research. Harlow, UK: Longman Group Ltd; 1982. p 63.
16. Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Shay JW, Toyama K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 1997;11:190-194.
17. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-2320.